BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9614555)

  • 1. Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters.
    Sallenave JM; Xing Z; Simpson AJ; Graham FL; Gauldie J
    Gene Ther; 1998 Mar; 5(3):352-60. PubMed ID: 9614555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
    Rein DT; Breidenbach M; Kirby TO; Han T; Siegal GP; Bauerschmitz GJ; Wang M; Nettelbeck DM; Tsuruta Y; Yamamoto M; Dall P; Hemminki A; Curiel DT
    Clin Cancer Res; 2005 Feb; 11(3):1327-35. PubMed ID: 15709205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide.
    Simpson AJ; Cunningham GA; Porteous DJ; Haslett C; Sallenave JM
    Hum Gene Ther; 2001 Jul; 12(11):1395-406. PubMed ID: 11485631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
    Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
    Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells.
    Higashimoto Y; Yamagata Y; Iwata T; Ishiguchi T; Okada M; Masuda M; Satoh H; Itoh H
    Respiration; 2005; 72(6):629-35. PubMed ID: 16355004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
    Sung RS; Qin L; Bromberg JS
    Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors.
    Arita E; Kondoh M; Isoda K; Nishimori H; Yoshida T; Mizuguchi H; Yagi K
    Eur J Pharm Biopharm; 2008 Sep; 70(1):1-6. PubMed ID: 18468873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of promoter activities for efficient expression into human B cells and haematopoietic progenitors with adenovirus Ad5/F35.
    Cayer MP; Drouin M; Sea SP; Forest A; Côté S; Simard C; Boyer L; Jacques A; Pineault N; Jung D
    J Immunol Methods; 2007 Apr; 322(1-2):118-27. PubMed ID: 17397859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
    Barker SD; Coolidge CJ; Kanerva A; Hakkarainen T; Yamamoto M; Liu B; Rivera AA; Bhoola SM; Barnes MN; Alvarez RD; Curiel DT; Hemminki A
    J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors.
    Kügler S; Meyn L; Holzmüller H; Gerhardt E; Isenmann S; Schulz JB; Bähr M
    Mol Cell Neurosci; 2001 Jan; 17(1):78-96. PubMed ID: 11161471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral vector platform for transduction of constitutive and regulated tricistronic or triple-transcript transgene expression in mammalian cells and microtissues.
    Gonzalez-Nicolini V; Sanchez-Bustamante CD; Hartenbach S; Fussenegger M
    J Gene Med; 2006 Oct; 8(10):1208-22. PubMed ID: 16960915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimicrobial/elastase inhibitor elafin regulates lung dendritic cells and adaptive immunity.
    Roghanian A; Williams SE; Sheldrake TA; Brown TI; Oberheim K; Xing Z; Howie SE; Sallenave JM
    Am J Respir Cell Mol Biol; 2006 May; 34(5):634-42. PubMed ID: 16424380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
    Hoffmann D; Jogler C; Wildner O
    J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells.
    Borrelli MJ; Schoenherr DM; Wong A; Bernock LJ; Corry PM
    Cancer Res; 2001 Feb; 61(3):1113-21. PubMed ID: 11221841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
    Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
    J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
    Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
    Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled transgene expression by E1-E4-defective adenovirus vectors harbouring a "tet-on" switch system.
    Fender P; Jeanson L; Ivanov MA; Colin P; Mallet J; Dedieu JF; Latta-Mahieu M
    J Gene Med; 2002; 4(6):668-75. PubMed ID: 12439858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.